In CMML, mutations in SRSF2 gene, which are frequently associated to mutations in TET2 gene, are identified in ~50% of the patients whereas mutations in other splice genes are found in an additional 10% of these patients [42-43]. This evidence concerns the gene SRSF2 and chronic myelomonocytic leukemia.